Create investor-ready financial projections for a Biotech business with this easy-to-use but powerful forecast template that will automatically produce pro forma statements for your biotechnology venture. Forecasting biotechnology ventures can be tricky given certification timelines and intermittent funding but this template will help create financials ready for your pitch deck and business plan.
Template price: $
99
Built specifically for Biotech businesses- ProjectionHub has helped more than 50,000 different businesses create financial projections for their business plans, loan applications, and pitch decks so you can be confident this biotech financial projection template will be effective and reliable
The template price: $
99
USD
100% money-back guarantee for 30 days!
After purchase, you will download an unlocked Excel file with a ready-to-use financial projection template for your business model. You can also open the file to use in Google Sheets!
Profit and loss at a glance table
Use of start-up funds graph
Key ratios table
Cash generated from operating activities graph
Investor dashboard
5 years of monthly and annual income statement, cash flow and balance sheet reports
We can fill out or modify any of the templates we sell, and we’re always happy to answer questions.
When you call us, you can speak directly to the developers of the model, not a call center or customer service representative.
Contact us in the most convenient way for you. We're here to help you
If the model doesn’t work for you, we’re happy to provide a refund.
If you hired a CPA to build this template from scratch it would take at least 20 hours of billable time to build a similar template. At an average hourly rate of $100 per hour it would cost you $2,000.
20 hours X $100 = $2,000 value
The template price: $
99
USD
100% money-back guarantee for 30 days
Before joining ProjectionHub, Grace served as an auditor for a public accounting firm in Indianapolis. There, she audited start-up tech companies, major regional hospitals, public manufacturers and everything in between.
As an auditor, she gained insight to the inner workings of all kinds of business models. Grace is a CPA, has a bachelor’s degrees in Accounting and French and a Master’s of Accountancy all from the University of Iowa, where she also taught introductory accounting classes to undergraduates.
Grace loves to use her accounting expertise to serve as an advisor to her clients, helping them understand what it takes to make a business succeed.
Adam is the co-founder of ProjectionHub which is a SaaS web application that helps entrepreneurs create financial projections for their business.
Since 2012, over 40,000 entrepreneurs from around the world have used ProjectionHub to help create financial projections.
Adam also serves as the Executive Director of Bankable. Bankable is a Small Business Administration (SBA) lender that makes loans from $500 to $250,000 to Indiana small businesses that are unable to secure financing from a traditional bank.
Adam has managed the loan program since loan #1 in 2010. Since 2010, Bankable has closed over 1,200 loans totaling over $38,000,000. Adam is an entrepreneur at heart and loves working with entrepreneurs to launch and grow their business.
We'll answer your questions about how the template works
We can help you customize your template, add revenue models, expenses or custom charts, tables and graphs -> with our financial modeling services
The approach that we decided to take in our biotech financial model was to start with the total population in the geography that you hope to get approval for your pharmaceutical or medical device, then estimate the percentage of the population that could have a medical need for your product, this will give you the total addressable market. From there, you should project what your market share or market penetration will be along with your price point in order to determine projected revenue.
One of the most difficult things about starting a biotech company is that you might not generate material revenue for years and years while you do R&D, then product testing, then apply for approval to sell your product. According to this Quora Q&A we see that it takes an average of 10 years from startup to first drug approval which means you can expect it to take at least a decade to generate material revenue.
Valuing a biotech startup that is pre revenue can be incredibly difficult. The challenge with biotech startup valuations is the all or nothing nature of most biotech startups. You either will get approval for your pharmaceutical or medical device and will have opportunity to generate massive profits, or you won't get approval which means your company never generates profit. The approach that investors seem to take is to try to understand what the potential profits and cash flows could be for a biotech company if they receive product approval and then they apply a percentage likelihood of receiving approval to determine a valuation. As the probability of approval increases, the valuation will increase as well.
